-
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study)D'Ascenzo F, Chieffo A, Cerrato E et al. -
Access Site and Outcomes for Unprotected Left Main Stem Percutaneous Coronary Intervention: An Analysis of the British Cardiovascular Intervention Society DatabaseKinnaird T, Anderson R, Gallagher S et al.
-
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery diseaseSerruys PW, Morice MC, SYNTAX Investigators.
-
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trialChen S, Redfors B, Stone GW et al.
-
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysisMS Sabatine, BA Bergmark, SA Murphy et al.
-
Intravascular ultrasound in the evaluation and treatment of left main coronary artery disease: a consensus statement from the European Bifurcation ClubMintz GS, Lefèvre T, Lassen JF et al.
-
Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) studyKim YH, Park DW, PRECOMBAT-2 Investigators.
-
Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trialHuang X, Redfors B, Stone GW et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
